Press Releases on April 28, 2021 - EIN Presswire - Press Release Distribution Service

Published on April 28, 2021 - 12:15 GMT

II-VI Incorporated Introduces Lithium-Sulfur/Selenium Cathode Technology for High-Energy and High-Power Lithium-Ion Batteries

PITTSBURGH, April 28, 2021 (GLOBE NEWSWIRE) -- II‐VI Incorporated (Nasdaq: IIVI), a leader in engineered materials, today announced that it will introduce its lithium-sulfur/selenium cathode technology for high-energy and high-power lithium-ion batteries …

Distribution channels:

Published on April 28, 2021 - 12:11 GMT

Four Questions About Debt and Financing Risks from COVID-19 in the Middle East and North Africa

A man walking in the Pakistan Stock Exchange building. The pandemic has increased financing needs in Pakistan and other countries across the region. (photo: IMF)By Jeta Menkulasi, Cesar Serra, and Suchanan Tambunlertchai IMF Middle East and …

Distribution channels: Banking, Finance & Investment Industry

Published on April 28, 2021 - 12:09 GMT

NordPass Sale: Secure your passwords with 70% off

LONDON, April 28, 2021 (GLOBE NEWSWIRE) -- The password manager NordPass is having a “Spring Forward” sale for its consumer solution. The state-of-the-art password manager is now available at a considerable discount, with 70% off the Premium 2-year plan …

Distribution channels: IT Industry, Media, Advertising & PR ...

Published on April 28, 2021 - 12:07 GMT

Galane Gold Ltd. Releases Financial and Operating Results for 2020

TORONTO, April 28, 2021 (GLOBE NEWSWIRE) -- Galane Gold Ltd. (“Galane Gold” or the “Company”) (TSX-V: GG; OTCQB: GGGOF) is pleased to announce the release of its financial results for the year ended December 31, 2020. All amounts are in United States …

Distribution channels: Business & Economy, Mining Industry ...

Published on April 28, 2021 - 12:05 GMT

Ayurcann Holdings Corp. Announces Closing of Oversubscribed Non-Brokered Financing

TORONTO, April 28, 2021 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. (CSE: AYUR) (the “Company” or “Ayurcann”) a Canadian extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products, is …

Distribution channels: Banking, Finance & Investment Industry, Energy Industry ...

Published on April 28, 2021 - 12:05 GMT

UNCF to Provide HBCU Faculty with Free Training in Effective Online Teaching and Course Design

WASHINGTON, DC, April 28, 2021 (GLOBE NEWSWIRE) -- UNCF (United Negro College Fund), has announced they will provide online learning professional development training for up to 1,500 faculty members at Historically Black Colleges and Universities (HBCUs) …

Distribution channels: Media, Advertising & PR ...

Published on April 28, 2021 - 12:05 GMT

TRACON to Report First Quarter 2021 Financial Results and Company Highlights on May 5, 2021

SAN DIEGO, April 28, 2021 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO- …

Distribution channels:

Published on April 28, 2021 - 12:05 GMT

Aeterna Zentaris Announces Virtual 2021 Annual Meeting of Shareholders

CHARLESTON, S.C., April 28, 2021 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests, today announced its …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on April 28, 2021 - 12:05 GMT

Silo Pharma (SILO) and Zylo Therapeutics, Inc. (ZTI) enter into Joint Venture Agreement to focus on the development of ketamine ...

Englewood Cliffs, NJ, April 28, 2021 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (OTCQB: SILO) a developmental stage biopharmaceutical company focused on the use of psychedelics as a therapeutic, today announced that it has entered into a Joint Venture with Zylo …

Distribution channels:

Published on April 28, 2021 - 12:02 GMT

Nkarta Receives NKX019 IND Clearance from U.S. Food and Drug Administration for Treatment of Relapsed/Refractory B Cell ...

NKX019 to be Nkarta’s second CAR NK pipeline program to enter clinical trial SOUTH SAN FRANCISCO, Calif., April 28, 2021 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies …

Distribution channels: